Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11


Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study.

Lauffenburger JC, Farley JF, Gehi AK, Rhoney DH, Brookhart MA, Fang G.

J Am Heart Assoc. 2015 Apr 10;4(4). pii: e001798. doi: 10.1161/JAHA.115.001798.


Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.

Lauffenburger JC, Farley JF, Gehi AK, Rhoney DH, Brookhart MA, Fang G.

Am J Cardiol. 2015 Apr 15;115(8):1095-101. doi: 10.1016/j.amjcard.2015.01.539. Epub 2015 Feb 2.


Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature.

Shenolikar R, Bruno AS, Eaddy M, Cantrell C.

Am Health Drug Benefits. 2011 Nov;4(7):465-74.


Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes.

Stevenson DG, O'Malley AJ, Dusetzina SB, Mitchell SL, Zarowitz BJ, Chernew ME, Newhouse JP, Huskamp HA.

J Am Geriatr Soc. 2014 Sep;62(9):1666-74. doi: 10.1111/jgs.12988. Epub 2014 Aug 14.


How patient cost-sharing trends affect adherence and outcomes: a literature review.

Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR.

P T. 2012 Jan;37(1):45-55.


Whom do older adults trust most to provide information about prescription drugs?

Donohue JM, Huskamp HA, Wilson IB, Weissman J.

Am J Geriatr Pharmacother. 2009 Apr;7(2):105-16. doi: 10.1016/j.amjopharm.2009.04.005.


Systematic review on quality control for drug management programs: is quality reported in the literature?

Holtorf AP, McAdam-Marx C, Schaaf D, Eng B, Oderda G.

BMC Health Serv Res. 2009 Feb 25;9:38. doi: 10.1186/1472-6963-9-38. Review.


The impact of the Medicare Part D prescription benefit on generic drug use.

Zhang JX, Yin W, Sun SX, Alexander GC.

J Gen Intern Med. 2008 Oct;23(10):1673-8. doi: 10.1007/s11606-008-0742-6. Epub 2008 Jul 26.


Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.

Donohue JM, Fischer MA, Huskamp HA, Weissman JS.

Health Serv Res. 2008 Oct;43(5 Pt 1):1557-75. doi: 10.1111/j.1475-6773.2008.00858.x. Epub 2008 May 13.


What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Gemmill MC, Thomson S, Mossialos E.

Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.


Supplemental Content

Support Center